Neoplasms

Urinary Tract, Sexual Organs, and Pregnancy Conditions

All Conditions

Prostatic Neoplasms

Adenocarcinoma

Genital Neoplasms, Male

Urogenital Neoplasms

Genital Diseases

Genital Diseases, Male

Urogenital Diseases

Prostatic Diseases

Male Urogenital Diseases

John Sylvester, MD

Steve Kurtzman, MD

The purpose of this study is to observe PSA response and incidence of side effects in patients diagnosed with intermediate to high risk prostate cancer and treated with Cesium-131 in combination of external beam therapy.

Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer

Dosimetric and Morbidity Outcomes of Cs-131 Brachytherapy in Combination With External Beam Radiation Therapy in Subjects With Intermediate to High Risk Adenocarcinoma of the Prostate: An Observational Study

Data collected for analysis will be total therapeutic dose delivered to the prostate by the Cs-131 brachytherapy implant treatment in units of Gy.

Data collected for analysis will be the EPIC prostate cancer quality of life questionnaire.

Data collected for analysis will be PSA measurements.

Swedish Medical Center

IsoRay Medical, Inc.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer	NCT00621413	Prostate Cancer		18 Years -	IsoRay Medical, Inc.
Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer	NCT00621413	Prostate Cancer		18 Years -	IsoRay Medical, Inc.

Spots Global Cancer Trial Database for intermediate and high risk cancer of the prostate